Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | -1.21% | +7.02% | -10.10% |
2023 | Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors | CI |
2023 | Angion Biomedia to Implement 10-for-1 Reverse Split | MT |
Sales 2021 | 28.31M 38.7M | Sales 2022 | 2.3M 3.15M | Capitalization | 24.44M 33.41M |
---|---|---|---|---|---|
Net income 2021 | -54M -73.81M | Net income 2022 | -38M -51.94M | EV / Sales 2021 | 0.1 x |
Net cash position 2021 | 84.09M 115M | Net cash position 2022 | 46.78M 63.94M | EV / Sales 2022 | -9.71 x |
P/E ratio 2021 |
-1.5
x | P/E ratio 2022 |
-0.63
x | Employees | 8 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | -1.21% | ||
Current month | -10.10% | ||
Current year | -10.10% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.99 | -1.21% | 37,127 |
24-04-25 | 9.1 | -1.62% | 19,886 |
24-04-24 | 9.25 | +0.33% | 24,650 |
24-04-23 | 9.22 | -5.34% | 19,431 |
24-04-22 | 9.74 | +15.95% | 68,337 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotes- Stock Market
- Equities
- ANGN Stock